Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Shingrix
Research
GSK seeks link between shingles vax and lower dementia risk
The new study takes advantage of the expansion of the U.K.’s national shingles immunization program, which naturally created two randomized cohorts.
Darren Incorvaia
Mar 25, 2025 5:00am
Curevo clinches $110M, nabs Moncef Slaoui to lead board
Mar 17, 2025 10:44am
Curevo’s shingles vaccine equals Shingrix in ph. 2 head-to-head
Jan 8, 2024 9:44am
Takeda spinout HilleVax hits Wall St., a test of choppy waters
Apr 7, 2022 10:48am
Curevo will go head-to-head against GSK's Shingrix with $60M
Feb 10, 2022 11:25am
Pfizer, BioNTech team up against GSK's Shingrix dominance
Jan 5, 2022 9:49am